HearUSA Honored for Client Care and Consultancy Services
The company received two distinctions in Global Health & Pharma’s 2026 Healthcare & Pharmaceutical Awards.
The company received two distinctions in Global Health & Pharma’s 2026 Healthcare & Pharmaceutical Awards.
The changes are designed to address workforce needs and create clearer routes to accreditation for both overseas-qualified and Australian audiologists.
The WSA Sound Preference program aims to reframe hearing aid counseling to include identifying individual sound preferences and thereby enable more personalized fittings, improved patient engagement, and better hearing aid satisfaction, and increase adoption.
The company plans a clinical trial for its CIL001 drug candidate at Massachusetts General Hospital and will triple preclinical capacity through its partnership with CBSET.
Spangler will succeed founding ACI Alliance executive director Donna Sorkin, officially assuming the role in mid-June.
Findings from the state's mandated program demonstrate a decreased age at first audiology visit and increased detection of mild hearing loss in infants.
The audiologist and researcher was hired to help accelerate the company’s clinical research in aural rehabilitation.
A multicenter study found a one-time treatment targeting the OTOF gene restored hearing in most participants, with effects lasting up to 2.5 years.
Oticon will present its newest hearing technology at the upcoming audiology conference.